LIDOCAINE HCL 2 % AND EPINEPHRIN 1:100000

国家: 以色列

语言: 英文

来源: Ministry of Health

有效成分:

EPINEPHRINE AS BITARTRATE; LIDOCAINE AS MONOHYDRATE

可用日期:

HENRY SCHEIN SHVADENT (2009 ) LTD

ATC代码:

N01BB02

药物剂型:

SOLUTION FOR INJECTION

组成:

LIDOCAINE AS MONOHYDRATE 20 MG/ML; EPINEPHRINE AS BITARTRATE 10 MCG/ML

给药途径:

DENTAL NERVE BLOCK, DENTAL INFILTRATION INJ.

处方类型:

Required

厂商:

NOVOCOL PHARMACEUTICAL OF CANADA INC.

治疗组:

LIDOCAINE

治疗领域:

LIDOCAINE

疗效迹象:

Production of local anesthesia by nerve block or infiltration technique.

授权日期:

2014-09-30

产品特点

2612-3
FPO
Physician’s Prescribing Information
Lidocaine HCL 2% and Epinephrine 1:100,000
1. NAME OF THE MEDICINAL PRODUCT:
Lidocaine HCL 2% and Epinephrine 1:100,000
2. QUALITATIVE AND QUANTITATIVE COMPOSITION:
1 ml of solution for injection contains 20 mg of lidocaine HCL (as
monohydrate) and 10 micrograms (1:100,000) of epinephrine (as
bitartrate).
Epinephrine bitartrate is also called adrenaline tartrate. Both names
are synonyms.
One cartridge of 1.8 ml of solution for injection contains 36 mg of
lidocaine hydrochloride (as monohydrate) and 18 micrograms of
epinephrine (as bitartrate).
Excipient(s) with known effect: This medicinal product contains 1.20
mg/ml potassium metabisulfite [equivalent to 0.422 mg/ml potassium
(0.0108 mmol/ml)].
For a full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM:
Solution for injection. Clear and colourless solution, practically
free from particles. The pH of the solution is adjusted to USP limits
with sodium hydroxide.
4. CLINICAL PARTICULARS:
4.1) Therapeutic indications:
For the production of local anaesthesia by nerve block or infiltration
technique.
Dental infiltration injection, dental nerve block.
4.2) Posology and method of administration:
Lidocaine HCL 2% and Epinephrine 1:100,000 is a sterile isotonic
solution containing a local anesthetic agent, Lidocaine Hydrochloride,
and a vasoconstrictor, Epinephrine (as bitartrate) and is
administered parenterally by injection.
The dosage of Lidocaine HCL 2% and Epinephrine 1:100,000 depends on
the physical status of the patient, the area of the oral cavity to be
anesthetized, the vascularity of the oral tissues, and the
technique of anesthesia used. The least volume of solution that
results in effective local anesthesia should be administered; time
should be allowed between injections to observe the patient for
manifestations of an adverse reaction. For specific techniques and
procedures of a local anesthesia in the oral cavity, refer to standard
textbooks.
Dosage requirements should be determined on an individu